Literature DB >> 20032290

Activation of hemostasis and decline in cognitive function in older people.

David J Stott1, Michele Robertson, Ann Rumley, Paul Welsh, Naveed Sattar, Christopher J Packard, James Shepherd, Stella Trompet, Rudi G J Westendorp, Anton J M de Craen, J Wouter Jukema, Brendan Buckley, Ian Ford, Gordon D O Lowe.   

Abstract

OBJECTIVE: To determine whether activation of hemostatic function (thrombosis and fibrinolysis) is associated with cognitive decline in older people. METHODS AND
RESULTS: We studied 5804 people (age, 70-82 years) in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Mean follow-up was 3.2 years, including annual measurement of speed of information processing (letter, digit coding, and Stroop), verbal memory (picture-word naming), and basic and instrumental activities of daily living. Raised levels of markers of thrombin generation (d-dimer and prothrombin fragment 1+2) were associated independently with increased rate of cognitive decline (eg, Stroop increased by 4.44 s [SEM, 0.68] in bottom tertile of d-dimer compared to 5.46 [SEM, 0.71] in highest tertile; P<0.05) and deterioration in activities of daily living. This increased rate of decline was attenuated but not removed when subjects with incident nonfatal stroke were omitted from the analysis. It also persisted when adjustments were made for inflammation (C-reactive protein and IL-6).
CONCLUSIONS: Older patients with increased markers of thrombin generation (d-dimer and prothrombin fragment 1+2) are at increased risk for cognitive decline and deterioration in ability to perform activities of daily living. This is likely attributable to increased risk of cerebral ischemic damage (including covert disease) associated with prothrombotic states.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032290     DOI: 10.1161/ATVBAHA.109.199448

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.

Authors:  S R Gillett; L A McClure; P W Callas; E L Thacker; F W Unverzagt; V G Wadley; A J Letter; M Cushman
Journal:  J Thromb Haemost       Date:  2018-06-06       Impact factor: 5.824

Review 2.  Vascular disease and dementias: paradigm shifts to drive research in new directions.

Authors:  Mitchel A Kling; John Q Trojanowski; David A Wolk; Virginia M Y Lee; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

3.  Depletion of coagulation factor XII ameliorates brain pathology and cognitive impairment in Alzheimer disease mice.

Authors:  Zu-Lin Chen; Alexey S Revenko; Pradeep Singh; A Robert MacLeod; Erin H Norris; Sidney Strickland
Journal:  Blood       Date:  2017-02-27       Impact factor: 22.113

4.  Association between cognition and gene polymorphisms involved in thrombosis and haemostasis.

Authors:  Terence J Quinn; Jahad Alghamdi; Sandosh Padmanabhan; David J Porteous; Blair H Smith; Lynne Hocking; Ian J Deary; John Gallacher; Martina Messow; David J Stott
Journal:  Age (Dordr)       Date:  2015-08-01

Review 5.  Fibrinogen and altered hemostasis in Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Daria Zamolodchikov; Hyung Jin Ahn; Sidney Strickland; Erin H Norris
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Apolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects.

Authors:  Cláudia N Ferreira; Maria G Carvalho; Karina B Gomes; Helton J Reis; Ana-Paula Fernandes; András Palotás; Marinez O Sousa
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-29

7.  Neuropsychiatric symptoms in patients with aortic aneurysms.

Authors:  Bernhard T Baune; Steven J Unwin; Frances Quirk; Jonathan Golledge
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

8.  ABO Blood Group and Dementia Risk--A Scandinavian Record-Linkage Study.

Authors:  Senthil K Vasan; Klaus Rostgaard; Henrik Ullum; Mads Melbye; Henrik Hjalgrim; Gustaf Edgren
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

9.  Genetic predictors of fibrin D-dimer levels in healthy adults.

Authors:  Nicholas L Smith; Jennifer E Huffman; David P Strachan; Jie Huang; Abbas Dehghan; Stella Trompet; Lorna M Lopez; So-Youn Shin; Jens Baumert; Veronique Vitart; Joshua C Bis; Sarah H Wild; Ann Rumley; Qiong Yang; Andre G Uitterlinden; David J Stott; Gail Davies; Angela M Carter; Barbara Thorand; Ozren Polašek; Barbara McKnight; Harry Campbell; Alicja R Rudnicka; Ming-Huei Chen; Brendan M Buckley; Sarah E Harris; Annette Peters; Drazen Pulanic; Thomas Lumley; Anton J M de Craen; David C Liewald; Christian Gieger; Susan Campbell; Ian Ford; Alan J Gow; Michelle Luciano; David J Porteous; Xiuqing Guo; Naveed Sattar; Albert Tenesa; Mary Cushman; P Eline Slagboom; Peter M Visscher; Tim D Spector; Thomas Illig; Igor Rudan; Edwin G Bovill; Alan F Wright; Wendy L McArdle; Geoffrey Tofler; Albert Hofman; Rudi G J Westendorp; John M Starr; Peter J Grant; Mahir Karakas; Nicholas D Hastie; Bruce M Psaty; James F Wilson; Gordon D O Lowe; Christopher J O'Donnell; Jacqueline C M Witteman; J Wouter Jukema; Ian J Deary; Nicole Soranzo; Wolfgang Koenig; Caroline Hayward
Journal:  Circulation       Date:  2011-04-18       Impact factor: 29.690

10.  Effect of Oral Anticoagulant Therapy on Coagulation Activity and Inflammatory Markers in Patients with Atrial Fibrillation Undergoing Ablation: A Randomized Comparison between Dabigatran and Warfarin.

Authors:  Shahideh Amini; Kheirollah Gholami; Hooman Bakhshandeh; Bahram Fariborz Farsad
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.